Comorbid obstructive sleep apnea is associated with adverse cardiovascular outcomes in female patients with acute coronary syndrome complicating metabolic syndrome.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical cardiology"
DOI: 10.1002/clc.24020
Abstract: BACKGROUND Obstructive sleep apnea (OSA) and metabolic syndrome (MetS) are each increasingly common in patients with acute coronary syndrome (ACS). Whether OSA increases cardiovascular consequences in ACS patients with MetS has not been investigated. HYPOTHESIS… read more here.
Keywords: acs patients; osa; patients mets; syndrome ... See more keywords
The Predictive Value of Lp(a) for Adverse Cardiovascular Event in ACS Patients With an Achieved LDL-C Target at Follow Up After PCI
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cardiovascular Translational Research"
DOI: 10.1007/s12265-021-10148-2
Abstract: Low-density lipoprotein cholesterol (LDL-C) is a traditional and important risk factor for atherosclerotic cardiovascular disease (CVD). Recently, lipoprotein (a) (lp(a)) attracts considerable attention as a residual risk factor for CVD. However, the roles of lp(a)… read more here.
Keywords: ldl 8mmol; adverse cardiovascular; acs patients; predictive value ... See more keywords
Long-Term Prognosis of Patients With Takotsubo Syndrome.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.06.016
Abstract: BACKGROUND Prognosis of Takotsubo syndrome (TTS) remains controversial due to scarcity of available data. Additionally, the effect of the triggering factors remains elusive. OBJECTIVES This study compared prognosis between TTS and acute coronary syndrome (ACS)… read more here.
Keywords: term; long term; prognosis; acs patients ... See more keywords
International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2021.03.309
Abstract: Background Published data suggest worse outcomes in acute coronary syndrome (ACS) patients and concurrent coronavirus disease 2019 (COVID-19) infection. Mechanisms remain unclear. Objectives The purpose of this study was to report the demographics, angiographic findings,… read more here.
Keywords: acs; acs patients; covid; acute coronary ... See more keywords
In-hospital outcome in patients presenting with acute coronary syndrome with left main coronary artery disease: A report from Japanese prospective multicenter percutaneous coronary intervention registry.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of cardiology"
DOI: 10.1016/j.jjcc.2019.11.006
Abstract: BACKGROUND Patients presenting with acute coronary syndrome (ACS) from left main (LM) disease are at a high risk for mortality despite recent advancement in devices and techniques during percutaneous coronary interventions (PCI). We aimed to… read more here.
Keywords: presenting acute; patients presenting; acs patients; mortality ... See more keywords
Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease.
Sign Up to like & getrecommendations! Published in 2022 at "Nature medicine"
DOI: 10.1038/s41591-022-01686-6
Abstract: Complex diseases, such as coronary artery disease (CAD), are often multifactorial, caused by multiple underlying pathological mechanisms. Here, to study the multifactorial nature of CAD, we performed comprehensive clinical and multi-omic profiling, including serum metabolomics… read more here.
Keywords: coronary artery; risk; acs patients; cad ... See more keywords
Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-96606-y
Abstract: Challenges remain for clinicians over balancing the efficacy of active antithrombotic therapy and simultaneous bleeding reduction in patients. The clinical data of 347 patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) were… read more here.
Keywords: group group; group; acs patients; efficacy ... See more keywords
Platelet-Released Extracellular Vesicle Characteristics Differ in Chronic and in Acute Heart Disease
Sign Up to like & getrecommendations! Published in 2022 at "Thrombosis and Haemostasis"
DOI: 10.1055/s-0043-57017
Abstract: BACKGROUND  Extracellular vesicles (EVs), shed in response to cell activation, stress, or injury, are increased in the blood of patients with cardiovascular disease. EVs are characterized by expressing parental-cell antigens, allowing the determination of their… read more here.
Keywords: acs patients; disease; acs; heart ... See more keywords
microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome.
Sign Up to like & getrecommendations! Published in 2021 at "Bioengineered"
DOI: 10.1080/21655979.2021.1967066
Abstract: Acute coronary syndrome (ACS) is one of the main syndromes of coronary artery disease with high mortality. The identification of biomarkers associated with disease occurrence and progression could improve early detection and risk prediction. This… read more here.
Keywords: mir 3646; mir; inflammatory response; acs patients ... See more keywords
ABCA1, TCF7, NFATC1, PRKCZ and PDGFA DNA methylation as potential epigenetic-sensitive targets in acute coronary syndrome via network analysis
Sign Up to like & getrecommendations! Published in 2021 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehab724.1367
Abstract: Acute coronary syndrome (ACS) is the most severe clinical manifestation of coronary heart disease and the leading cause of death worldwide. To perform an epigenome-wide analysis in circulating CD4+ and CD8+ T cells of ACS… read more here.
Keywords: methylation; dna; analysis; acs patients ... See more keywords
Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
Sign Up to like & getrecommendations! Published in 2021 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehab724.1414
Abstract: Based on data from randomized controlled trials, both American and European guidelines recommend treating acute coronary syndrome (ACS) patients with second generation P2Y12 inhibitors.1,2 Direct head-to-head comparison of these agents was scarce until the recent… read more here.
Keywords: inhibitor; p2y12 inhibitor; acs patients; irreversible thienopyridine ... See more keywords